Current Ratio of Edesa Biotech, Inc. from 30 Jun 2015 to 31 Dec 2025
- Taxonomy & unit
- ratio: x
- Description
- The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
- Summary
-
Edesa Biotech, Inc. quarterly Current Ratio in x history and change rate from 30 Jun 2015 to 31 Dec 2025.
- Edesa Biotech, Inc. Current Ratio for the quarter ending 31 Dec 2025 was 15.01x, a 1022% increase year-over-year.
Current Ratio, Quarterly (x)
Current Ratio, YoY Quarterly Change (%)
Edesa Biotech, Inc. Quarterly Current Ratio (x)
| Period | Value | YoY Chg | Change % | Date |
|---|---|---|---|---|
| Q4 2025 | 15.01x | +13.68x | +1022% | 31 Dec 2025 |
| Q3 2025 | 8.92x | +7.19x | +417% | 30 Sep 2025 |
| Q2 2025 | 5.81x | +3.51x | +152% | 30 Jun 2025 |
| Q1 2025 | 3.02x | -0.05x | -1.6% | 31 Mar 2025 |
| Q4 2024 | 1.34x | -2.56x | -66% | 31 Dec 2024 |
| Q3 2024 | 1.73x | -3.21x | -65% | 30 Sep 2024 |
| Q2 2024 | 2.3x | -2.8x | -55% | 30 Jun 2024 |
| Q1 2024 | 3.07x | -0.83x | -21% | 31 Mar 2024 |
| Q4 2023 | 3.9x | -0.24x | -5.8% | 31 Dec 2023 |
| Q3 2023 | 4.93x | +0.88x | +22% | 30 Sep 2023 |
| Q2 2023 | 5.1x | +0.58x | +13% | 30 Jun 2023 |
| Q1 2023 | 3.9x | -3.32x | -46% | 31 Mar 2023 |
| Q4 2022 | 4.14x | -2.42x | -37% | 31 Dec 2022 |
| Q3 2022 | 4.05x | -2.92x | -42% | 30 Sep 2022 |
| Q2 2022 | 4.52x | -1.89x | -29% | 30 Jun 2022 |
| Q1 2022 | 7.22x | +1.82x | +34% | 31 Mar 2022 |
| Q4 2021 | 6.55x | -0.8x | -11% | 31 Dec 2021 |
| Q3 2021 | 6.97x | -0.04x | -0.5% | 30 Sep 2021 |
| Q2 2021 | 6.41x | -2.43x | -28% | 30 Jun 2021 |
| Q1 2021 | 5.4x | -3.67x | -40% | 31 Mar 2021 |
| Q4 2020 | 7.36x | -1.05x | -12% | 31 Dec 2020 |
| Q3 2020 | 7x | -2.56x | -27% | 30 Sep 2020 |
| Q2 2020 | 8.84x | -2.55x | -22% | 30 Jun 2020 |
| Q1 2020 | 9.07x | -8.07x | -47% | 31 Mar 2020 |
| Q4 2019 | 8.4x | -9.41x | -53% | 31 Dec 2019 |
| Q3 2019 | 9.56x | -5.99x | -39% | 30 Sep 2019 |
| Q2 2019 | 11.39x | -3.52x | -24% | 30 Jun 2019 |
| Q1 2019 | 17.14x | +4.16x | +32% | 31 Mar 2019 |
| Q4 2018 | 17.81x | +0.77x | +4.5% | 31 Dec 2018 |
| Q3 2018 | 15.55x | -3.99x | -20% | 30 Sep 2018 |
| Q2 2018 | 14.91x | -4.36x | -23% | 30 Jun 2018 |
| Q1 2018 | 12.98x | -2.93x | -18% | 31 Mar 2018 |
| Q4 2017 | 17.04x | +2.44x | +17% | 31 Dec 2017 |
| Q3 2017 | 19.54x | +5.9x | +43% | 30 Sep 2017 |
| Q2 2017 | 19.26x | +11.37x | +144% | 30 Jun 2017 |
| Q1 2017 | 15.92x | +8.83x | +125% | 31 Mar 2017 |
| Q4 2016 | 14.6x | +9.24x | +172% | 31 Dec 2016 |
| Q3 2016 | 13.64x | +9.56x | +234% | 30 Sep 2016 |
| Q2 2016 | 7.9x | +2.57x | +48% | 30 Jun 2016 |
| Q1 2016 | 7.09x | 31 Mar 2016 | ||
| Q4 2015 | 5.36x | 31 Dec 2015 | ||
| Q3 2015 | 4.09x | 30 Sep 2015 | ||
| Q2 2015 | 5.33x | 30 Jun 2015 |
* An asterisk sign (*) next to the value indicates that the value is likely invalid.